Internal Server Error

About ACT Grants

ACT Grants, an accelerator and incubator program founded in 2020, is based in Bengaluru, India. With a presence in 5 countries, it has supported around 81 startups in sectors like Enterprise Applications, HealthTech. As of Apr 2026, ACT Grants has 2 unicorns under its belt and has witnessed 5 portfolio exits. Most notable companies in its portfolio include Tata 1mg, Mozark and Medanta. The program is backed by a team of 27 people who primarily support Grant (prize money) startups based in India. Its latest investment was a Undisclosed Grant (prize money) round in RenewCred on Jan 15, 2026 along with Social Innovation Lab.
Key Metrics
Founded Year
2020
Location
Bengaluru, India
Portfolio Companies
Stages of Investment
Grant (prize money) & Seed
Locations of Investment
Unicorn in Portfolio

ACT Grants' List of Top Investments

ACT Grants has a portfolio of 81 companies, including 2 unicorns. Their most notable investments include Tata 1mg and Mozark.Their portfolio spans across India, United States, Senegal and 2 more locations. They have invested in Enterprise Applications, HealthTech, High Tech and 24 other sectors, across stages such as Grant (prize money), Seed stages. Here is the list of top investments by ACT Grants:
Provider of an online pharmacy with doctor listing and teleconsultation services. It offers pharmacy store where the user to view medicines, compare prices, and purchase online. It allow users to upload prescriptions for placing the order. It provides an online doctor consultation and lab test platform that allows users to search for doctors and book appointments. The platform sells fitness supplements, healthcare products, healthcare devices, and alternate medicines.

Key facts about Tata 1mg

  • Founded Year: 2015
  • Location: Delhi (India)
  • Annual Revenue: ₹2,360Cr as on Mar 31, 2025
  • Last Known Valuation: $*****
  • Stage: Acquired
  • Total Funding till date: $231M
  • Employee Count: 4,722 as on Aug 31, 2025
  • Investors: Maverick Ventures, IFC and 36 Others
  • Latest Funding Round: Series D, Sep 02, 2022, $*****
  • Highlight: Acquired
Provider of digital experience monitoring platform using synthetic testing and automation. The platform offers tools to monitor and identify failure points in digital journeys. It helps to assess, analyze, and enhance digital experience. The platform supports regulators, public entities, enterprises, and operators. It delivers insights into network performance through testing and analytics.

Key facts about Mozark

  • Founded Year: 2019
  • Location: Singapore (Singapore)
  • Annual Revenue: ₹22.4Cr as on Mar 31, 2024
  • Stage: Series B
  • Total Funding till date: $50M
  • Employee Count: 121 as on Mar 31, 2026
  • Investors: IFC, BlackSoil and 4 Others
  • Latest Funding Round: Series B, Mar 10, 2026, $*****
  • Highlight: Editors' Pick
Chain of multi-super specialty healthcare hospitals. It specializes in Cardiac Surgery, Liver and Kidney Transplants, Robotic Surgeries in Cardiology, Urology, Neurology and Neurosciences, Paediatrics, Orthopaedics, and Gynecology, and advanced cancer treatments. It also provides online doctor consultations, appointment booking, pharmacy home delivery, home care, radiology, air ambulance, health checkup, and lab services.

Key facts about Medanta

  • Founded Year: 2004
  • Location: Gurugram (India)
  • Annual Revenue: ₹3,770Cr as on Mar 31, 2025
  • Stage: Public
  • Total Funding till date: $105M
  • Employee Count: 5,760 as on Mar 31, 2025
  • Investors: Temasek, RJ Corp and 10 Others
  • Latest Funding Round: PE, Dec 18, 2013, $*****
  • Highlight: Public
Provider of educational platforms and solutions designed for personalized learning. It offers technology-based solutions aimed at optimizing educational impact. The solutions include SwiftChat a conversational AI platform designed to help learners via bots and interactive content, SwiftPAL a personalized Adaptive Learning system that adapts learning paths to individual student needs, and Swift Insights is a data and analytics systems to track learning outcomes using advanced measurement methods.

Key facts about ConveGenius

Developer of point-of-care molecular diagnostic platform for infectious disease detection. The solution includes Trueprep a fully automatic universal cartridge-based sample prep device, Prolab Atlus portable x-ray system, Thermalytix AI-based thermal scanning device, and Truelab, a real-time, quantitative micro-PCR analyzer that targets diseases like rifampicin resistance, COVID‑19, influenza, dengue, hepatitis, HPV, malaria, and others.

Key facts about Molbio Diagnostics

  • Founded Year: 2000
  • Location: Salcete (India)
  • Annual Revenue: ₹1,030Cr as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series C
  • Total Funding till date: $124M
  • Employee Count: 714 as on May 31, 2025
  • Investors: Temasek, Motilal Oswal Private Equity and 36 Others
  • Latest Funding Round: Grant (prize money), 2023, $*****
  • Highlight: Editors' Pick

ACT Grants' Investments by Stage

ACT Grants has made 61 investments in Grant (prize money) stage with an average round size of $1.3M and 2 investments in Seed stage with an average round size of $7M.
Here are ACT Grants' investments by stage:
Stage of entry
No. of Investments
Grant (prize money)
61
Seed
2
Breakdown of ACT Grants' investments by stage of entryGrant (prize money) (61)Seed (2)
Note: We have considered here, only first round of investments

ACT Grants' Investments by Sector

ACT Grants has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, Sustainability Tech, High Tech and Consumer. Notably, it has invested in 62 Tech companies, 52 Enterprise (B2B) companies, 33 Consumer (B2C) companies and at least 23 companies focusing on Software.
Here are ACT Grants' investments by sector:
Sector
No. of Investments
Enterprise Applications
19
HealthTech
16
Sustainability Tech
12
High Tech
11
Consumer
8
Others
67
Breakdown of ACT Grants' investments by sectorsEnterprise Applic... (19)HealthTech (16)
Note: We have considered here, only first round of investments

ACT Grants' Investments by Geography

ACT Grants has made most investments in India (56), followed by United States where it has made 8 investments.
Here are ACT Grants' investments by geography:
Country
No. of Investments
India
56
United States
8
Senegal
1
Singapore
1
United Kingdom
1
Breakdown of ACT Grants' investments by countriesIndia (56)United States (8)
Note: We have considered here, only first round of investments

ACT Grants' recent investments

ACT Grants has made 1 investments in 2026 so far - RenewCred.
Here are the most recent investments by ACT Grants:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jan 15, 2026
India
Grant (prize money)
1851
Sep 02, 2025
India
Grant (prize money)
2145
  [+1]
Jul 10, 2025
India
Grant (prize money)
2528
-
Jul 10, 2025
India
Grant (prize money)
1496
-
Jul 10, 2025
-
Grant (prize money)
4045
-

Unicorns in ACT Grants' Portfolio

ACT Grants has 2 unicorns in its portfolio - Molbio Diagnostics and Zetwerk. The most recent unicorn in their portfolio is Molbio Diagnostics. It became a unicorn in 2022.
Here is a list of unicorns in ACT Grants' portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
71
Developer of point-of-care molecular diagnostic platform for infectious disease detection
2000
Salcete
Series C
sozmspg
63
Manufacturing platform that connects businesses with a global network of suppliers for custom production
2018
Bengaluru
Series F
vwrmbiv

IPOs and Publicly Listed companies in ACT Grants' Portfolio

2 of ACT Grants' portfolio companies have become public. Medanta got listed on the Bombay Stock Exchange (BSE), National Stock Exchange (NSE), in Nov 2022 at marketcap of $1.09B and Arvind got listed on the National Stock Exchange (NSE).
Here are ACT Grants' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Nov 16, 2022
-
-
4347
Feb 08, 1995
Sep 15, 2020
Grant (prize money)
1115

Acquired companies in ACT Grants' Portfolio

3 companies from ACT Grants' portfolio have been acquired. The most recent acquisition were Goodera in Dec 2023 by Uniqus.
Here are ACT Grants' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Dec 06, 2023
2023
Grant (prize money)
1308
Mar 20, 2022
2022
Grant (prize money)
9879
May 14, 2021
Jun 20, 2020
Grant (prize money)
2548

Team profile of ACT Grants

ACT Grants has a team of 27 members including 5 Partners located in India. ACT Grants' team sits on the board of 2 companies.
Here is a list of top team members in ACT Grants:
Name
Designation
Location
Board Memberships
Contact Details
Partner
India
-
Partner
Delhi
Cars24, Comviva and 4 more
Partner
Mumbai
-
-
Partner
Bengaluru
Partner
Mumbai
-

Co-investors of ACT Grants

Over the past 6 years, 1183 investors have co-invested in ACT Grants's portfolio companies. This includes funds and angels.

  • Invested before ACT GrantsAngel List, Peak XV Partners and 881 others have invested in rounds before ACT Grants. There are 5 companies where Angel List has invested before ACT Grants and 4 companies where Peak XV Partners has invested before ACT Grants.
  • Top Co-investors of ACT Grants15 investors entered a company along with ACT Grants. These include investors like UNIDO (1 company).
  • Invested after ACT GrantsA total of 285 investors have invested in ACT Grants's portfolio after their investments. Top Investors include Peak XV Partners (3 companies) and Stride Ventures (2 companies).

Recent News related to ACT Grants

View all news related to ACT Grants

FAQs about ACT Grants

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford